NIH Funds Research for Prostate Cancer Therapeutic Targets

NIH Funds Research for Prostate Cancer Therapeutic Targets
University of Houston researchers, led by assistant professor Daniel Frigo, have received two grants totaling $2.3 million from the National Institutes of Health’s National Cancer Institute to study two biochemical mechanisms, downstream of androgen receptors (AR), that are important in the pathogenesis of prostate cancer. Both studies, aiming for better disease detection and treatment, are being developed

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *